DUPONT MERCK Tc-99m MARKER IS 90% ACCURATE IN DETECTING BREAST CANCER, STUDY SHOWS; SEPARATE TRIAL SUPPORTS ULTRASOUND AS ADJUNCT TO MAMMOGRAPHY
This article was originally published in The Gray Sheet
Executive Summary
Scintimammography performed with Dupont Merck's technecium-99m sestamibi nuclear marker can correctly identify more than 90% of cancers in women with "suspicious" tissue masses, Iraj Khalkhali, MD, University of California, Los Angeles, reported in a Nov. 28 press conference at the Radiological Society of North America's annual meeting in Chicago.